Privia Health Group (NASDAQ:PRVA) CFO Sells $133,134.36 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 5,829 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $22.84, for a total transaction of $133,134.36. Following the transaction, the chief financial officer directly owned 161,903 shares in the company, valued at approximately $3,697,864.52. This trade represents a 3.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.

David Mountcastle also recently made the following trade(s):

• On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The shares were sold at an average price of $23.15, for a total value of $119,847.55.
• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $134,025.00.
• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The stock was sold at an average price of $25.05, for a total value of $192,809.85.
• On Friday, December 12th, David Mountcastle sold 23,887 shares of Privia Health Group stock. The stock was sold at an average price of $25.03, for a total value of $597,891.61.

Privia Health Group Stock Down 1.5%

Shares of NASDAQ PRVA opened at $21.73 on Friday. Privia Health Group, Inc. has a twelve month low of $18.77 and a twelve month high of $26.51. The firm has a market cap of $2.69 billion, a PE ratio of 127.82, a price-to-earnings-growth ratio of 1.39 and a beta of 0.82. The business has a fifty day simple moving average of $22.93 and a two-hundred day simple moving average of $23.58.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Thursday, February 26th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.21. The business had revenue of $541.17 million for the quarter, compared to the consensus estimate of $516.61 million. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The business’s revenue was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.21 EPS. On average, research analysts expect that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Analyst Ratings Changes

PRVA has been the topic of a number of research reports. Jefferies Financial Group reissued a “buy” rating and set a $32.00 target price on shares of Privia Health Group in a research report on Thursday, February 26th. Piper Sandler reaffirmed an “overweight” rating and issued a $36.00 price target on shares of Privia Health Group in a research report on Thursday, February 26th. Royal Bank Of Canada started coverage on shares of Privia Health Group in a research note on Friday, January 9th. They set an “outperform” rating and a $31.00 price objective on the stock. Citigroup cut their price objective on shares of Privia Health Group from $34.00 to $32.00 and set a “buy” rating on the stock in a report on Tuesday, March 3rd. Finally, Canaccord Genuity Group upped their target price on Privia Health Group from $34.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, February 27th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $31.00.

Institutional Trading of Privia Health Group

Several hedge funds have recently modified their holdings of PRVA. Bayban purchased a new position in shares of Privia Health Group in the 4th quarter worth approximately $26,000. Invesco Ltd. raised its stake in shares of Privia Health Group by 5.1% during the 4th quarter. Invesco Ltd. now owns 427,615 shares of the company’s stock worth $10,139,000 after acquiring an additional 20,652 shares in the last quarter. Wellington Management Group LLP lifted its position in Privia Health Group by 3.8% during the fourth quarter. Wellington Management Group LLP now owns 233,446 shares of the company’s stock valued at $5,535,000 after acquiring an additional 8,531 shares during the last quarter. Millennium Management LLC lifted its position in Privia Health Group by 19.0% during the fourth quarter. Millennium Management LLC now owns 702,744 shares of the company’s stock valued at $16,662,000 after acquiring an additional 112,428 shares during the last quarter. Finally, Gotham Asset Management LLC boosted its stake in Privia Health Group by 22.4% in the fourth quarter. Gotham Asset Management LLC now owns 36,995 shares of the company’s stock valued at $877,000 after acquiring an additional 6,773 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.